- call +1-201-465-4211
- email sales@mrinsights.biz
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
Scope of the Report:
This report focuses on the NGS-based RNA-seq in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
The worldwide market for NGS-based RNA-seq is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
SBS
SMRT
Market Segment by Applications, can be divided into
Transcriptome Epigenetics
Small RNA
There are 15 Chapters to deeply display the global NGS-based RNA-seq market.
Chapter 1, to describe NGS-based RNA-seq Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of NGS-based RNA-seq, with sales, revenue, and price of NGS-based RNA-seq, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of NGS-based RNA-seq, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, NGS-based RNA-seq market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe NGS-based RNA-seq sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 NGS-based RNA-seq Introduction
1.2 Market Analysis by Type
1.2.1 SBS
1.2.2 SMRT
1.3 Market Analysis by Applications
1.3.1 Transcriptome Epigenetics
1.3.2 Small RNA
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Illumina
2.1.1 Business Overview
2.1.2 NGS-based RNA-seq Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Illumina NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Thermo Fisher Scientific
2.2.1 Business Overview
2.2.2 NGS-based RNA-seq Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Thermo Fisher Scientific NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pacific Biosciences Of California
2.3.1 Business Overview
2.3.2 NGS-based RNA-seq Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pacific Biosciences Of California NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Qaigen
2.4.1 Business Overview
2.4.2 NGS-based RNA-seq Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Qaigen NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche
2.5.1 Business Overview
2.5.2 NGS-based RNA-seq Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Agilent Technologies
2.6.1 Business Overview
2.6.2 NGS-based RNA-seq Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Agilent Technologies NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Oxford Nanopore Technologies
2.7.1 Business Overview
2.7.2 NGS-based RNA-seq Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Perkinelmer
2.8.1 Business Overview
2.8.2 NGS-based RNA-seq Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Perkinelmer NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eurofins Scientific
2.9.1 Business Overview
2.9.2 NGS-based RNA-seq Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eurofins Scientific NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Gatc Biotech
2.10.1 Business Overview
2.10.2 NGS-based RNA-seq Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Gatc Biotech NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Macrogen
2.11.1 Business Overview
2.11.2 NGS-based RNA-seq Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Macrogen NGS-based RNA-seq Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global NGS-based RNA-seq Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global NGS-based RNA-seq Sales and Market Share by Manufacturer (2016-2017)
3.2 Global NGS-based RNA-seq Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 NGS-based RNA-seq Manufacturer Market Share in 2017
3.3.2 Top 6 NGS-based RNA-seq Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global NGS-based RNA-seq Market Analysis by Regions
4.1 Global NGS-based RNA-seq Sales, Revenue and Market Share by Regions
4.1.1 Global NGS-based RNA-seq Sales and Market Share by Regions (2013-2018)
4.1.2 Global NGS-based RNA-seq Revenue and Market Share by Regions (2013-2018)
4.2 North America NGS-based RNA-seq Sales and Growth Rate (2013-2018)
4.3 Europe NGS-based RNA-seq Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific NGS-based RNA-seq Sales and Growth Rate (2013-2018)
4.5 South America NGS-based RNA-seq Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa NGS-based RNA-seq Sales and Growth Rate (2013-2018)
5 North America NGS-based RNA-seq by Countries
5.1 North America NGS-based RNA-seq Sales, Revenue and Market Share by Countries
5.1.1 North America NGS-based RNA-seq Sales and Market Share by Countries (2013-2018)
5.1.2 North America NGS-based RNA-seq Revenue and Market Share by Countries (2013-2018)
5.2 United States NGS-based RNA-seq Sales and Growth Rate (2013-2018)
5.3 Canada NGS-based RNA-seq Sales and Growth Rate (2013-2018)
5.4 Mexico NGS-based RNA-seq Sales and Growth Rate (2013-2018)
6 Europe NGS-based RNA-seq by Countries
6.1 Europe NGS-based RNA-seq Sales, Revenue and Market Share by Countries
6.1.1 Europe NGS-based RNA-seq Sales and Market Share by Countries (2013-2018)
6.1.2 Europe NGS-based RNA-seq Revenue and Market Share by Countries (2013-2018)
6.2 Germany NGS-based RNA-seq Sales and Growth Rate (2013-2018)
6.3 UK NGS-based RNA-seq Sales and Growth Rate (2013-2018)
6.4 France NGS-based RNA-seq Sales and Growth Rate (2013-2018)
6.5 Russia NGS-based RNA-seq Sales and Growth Rate (2013-2018)
6.6 Italy NGS-based RNA-seq Sales and Growth Rate (2013-2018)
7 Asia-Pacific NGS-based RNA-seq by Countries
7.1 Asia-Pacific NGS-based RNA-seq Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific NGS-based RNA-seq Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific NGS-based RNA-seq Revenue and Market Share by Countries (2013-2018)
7.2 China NGS-based RNA-seq Sales and Growth Rate (2013-2018)
7.3 Japan NGS-based RNA-seq Sales and Growth Rate (2013-2018)
7.4 Korea NGS-based RNA-seq Sales and Growth Rate (2013-2018)
7.5 India NGS-based RNA-seq Sales and Growth Rate (2013-2018)
7.6 Southeast Asia NGS-based RNA-seq Sales and Growth Rate (2013-2018)
8 South America NGS-based RNA-seq by Countries
8.1 South America NGS-based RNA-seq Sales, Revenue and Market Share by Countries
8.1.1 South America NGS-based RNA-seq Sales and Market Share by Countries (2013-2018)
8.1.2 South America NGS-based RNA-seq Revenue and Market Share by Countries (2013-2018)
8.2 Brazil NGS-based RNA-seq Sales and Growth Rate (2013-2018)
8.3 Argentina NGS-based RNA-seq Sales and Growth Rate (2013-2018)
8.4 Colombia NGS-based RNA-seq Sales and Growth Rate (2013-2018)
9 Middle East and Africa NGS-based RNA-seq by Countries
9.1 Middle East and Africa NGS-based RNA-seq Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa NGS-based RNA-seq Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa NGS-based RNA-seq Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia NGS-based RNA-seq Sales and Growth Rate (2013-2018)
9.3 UAE NGS-based RNA-seq Sales and Growth Rate (2013-2018)
9.4 Egypt NGS-based RNA-seq Sales and Growth Rate (2013-2018)
9.5 Nigeria NGS-based RNA-seq Sales and Growth Rate (2013-2018)
9.6 South Africa NGS-based RNA-seq Sales and Growth Rate (2013-2018)
10 Global NGS-based RNA-seq Market Segment by Type
10.1 Global NGS-based RNA-seq Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global NGS-based RNA-seq Sales and Market Share by Type (2013-2018)
10.1.2 Global NGS-based RNA-seq Revenue and Market Share by Type (2013-2018)
10.2 SBS Sales Growth and Price
10.2.1 Global SBS Sales Growth (2013-2018)
10.2.2 Global SBS Price (2013-2018)
10.3 SMRT Sales Growth and Price
10.3.1 Global SMRT Sales Growth (2013-2018)
10.3.2 Global SMRT Price (2013-2018)
11 Global NGS-based RNA-seq Market Segment by Application
11.1 Global NGS-based RNA-seq Sales Market Share by Application (2013-2018)
11.2 Transcriptome Epigenetics Sales Growth (2013-2018)
11.3 Small RNA Sales Growth (2013-2018)
12 NGS-based RNA-seq Market Forecast (2018-2023)
12.1 Global NGS-based RNA-seq Sales, Revenue and Growth Rate (2018-2023)
12.2 NGS-based RNA-seq Market Forecast by Regions (2018-2023)
12.2.1 North America NGS-based RNA-seq Market Forecast (2018-2023)
12.2.2 Europe NGS-based RNA-seq Market Forecast (2018-2023)
12.2.3 Asia-Pacific NGS-based RNA-seq Market Forecast (2018-2023)
12.2.4 South America NGS-based RNA-seq Market Forecast (2018-2023)
12.2.5 Middle East and Africa NGS-based RNA-seq Market Forecast (2018-2023)
12.3 NGS-based RNA-seq Market Forecast by Type (2018-2023)
12.3.1 Global NGS-based RNA-seq Sales Forecast by Type (2018-2023)
12.3.2 Global NGS-based RNA-seq Market Share Forecast by Type (2018-2023)
12.4 NGS-based RNA-seq Market Forecast by Application (2018-2023)
12.4.1 Global NGS-based RNA-seq Sales Forecast by Application (2018-2023)
12.4.2 Global NGS-based RNA-seq Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure NGS-based RNA-seq Picture
Table Product Specifications of NGS-based RNA-seq
Figure Global Sales Market Share of NGS-based RNA-seq by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
